BBIO fund manager activity
BridgeBio Pharma, Inc · Nasdaq. Reported by 6 tracked fund managers in their 13F filings, Q2 2019 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 345,351 | $25,721,741 | 0.01% | Aug 4, 2026 |
| Polen Capital Management | Trimmed | 4,002 | $298,069 | 0.00% | Aug 4, 2026 |
| Viking Global Investors | Trimmed | 9,949,219 | $741,017,831 | 2.11% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Added | 351,628 | $26,111,894 | 0.01% | May 5, 2026 |
| Polen Capital Management | Added | 45,934 | $3,411,059 | 0.02% | May 14, 2026 |
| Viking Global Investors | Trimmed | 11,842,434 | $879,419,149 | 2.46% | May 15, 2026 |
Older quarters